Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication
about
The impact of environmental factors in severe psychiatric disorders.Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug developmentMood episodes and mood disorders: patterns of incidence and conversion in the first three decades of lifeThe genetics of bipolar disorderPrevention of bipolar disorder in at-risk children: Theoretical assumptions and empirical foundationsAdjunctive antioxidants for bipolar disorderBipolar disorder: new perspectives in health care and preventionEvidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of NeurologyEarly-onset bipolar spectrum disorders: diagnostic issuesA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisThe role of sleep in bipolar disorderBipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implicationsPharmacological Approaches for Treatment-resistant Bipolar DisorderLurasidone for the treatment of bipolar depression: an evidence-based reviewAssessment and treatment of mood disorders in the context of substance abuseCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersCurrent status of co-occurring mood and substance use disorders: a new therapeutic targetKetamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacyBipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlatesStructural invariance of General Behavior Inventory (GBI) scores in Black and White young adultsQuetiapine monotherapy in bipolar II depression: combined data from four large, randomized studiesAbuse and misuse of antidepressantsDiacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases: An UpdateThe International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of GuidelinesEmergent treatments based on the pathophysiology of bipolar disorder: A selective reviewThe development and course of bipolar spectrum disorders: an integrated reward and circadian rhythm dysregulation modelInvestigating the mechanism(s) underlying switching between states in bipolar disorderNeurocognitive correlates of emotional stimulus processing in pediatric bipolar disorder: a reviewTreatment of bipolar disorderMolecular actions and clinical pharmacogenetics of lithium therapyApplications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series.Genome-wide association study in bipolar patients stratified by co-morbidityBipolar disorder: candidate drug targets.Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestryBehavioral addictions in euthymic patients with bipolar I disorder: a comparison to controls.Harnessing the potential of community-based participatory research approaches in bipolar disorderSelf over time: another difference between borderline personality disorder and bipolar disorder.Where lies the risk? An ecological approach to understanding child mental health risk and vulnerabilities in sub-saharan AfricaPsychosocial Interventions for Bipolar Disorder: Perspective from the Behavioral Approach System (BAS) Dysregulation Theory
P2860
Q21129355-F3311E53-DB4F-4AAB-9AF5-EE8F1CD185F6Q22241837-FD0C0CD2-C651-472F-9C39-AF9EFBE8E014Q22242604-2FA04564-15F1-4D3A-9A1B-8FC8B140BEDBQ22251249-783546D7-2122-4C64-9268-B68BD2DD92ECQ22251374-912F07F4-7B05-4C35-AE34-D3D482DEFD59Q24198987-48A4C83D-F090-4AF5-9DA2-1FABD5B6DEDEQ24606335-4F162A48-0C2B-45CA-AE4D-7283E7E29A98Q24615757-65B95D60-0716-4DC0-8666-E924EDF80674Q24619731-E51C01E3-DBFF-4F96-9FCA-551CB30A31E7Q24630153-E3DB9229-ADA7-4EC2-9688-820925835C17Q24651407-CFFE217F-716F-45D9-B33D-7AD9199DB32CQ26740214-8500EC3B-97A3-42A3-85E9-23841623404EQ26743925-E46AFD0F-8EC4-42A5-B985-01CC44DB6B96Q26783002-3495EE8B-558B-44B3-9D5A-05E00E1D68D4Q26796437-6419A7B8-ACB3-4AE7-9549-F22498105DD6Q26798232-882FEE3A-C2AB-4EBE-9EA6-AC1FD2403F3FQ27009995-BDED6FB1-A69E-4481-9959-E49F64987499Q27014938-A65186A1-0504-41B0-B64C-0CF1A4CE102DQ27024227-0B3E77BA-D658-46B5-8CDE-187FF205AE42Q27025413-AF063CD0-978D-4FAE-AF4F-5122FAF39D03Q27333566-D81FD52C-BC2D-47B1-8C38-46FB9FAFDDC1Q27499305-6E733BED-2DB7-4E3C-B50D-6F879D31F24DQ27691354-4E886A83-5D31-40BF-B953-16AC8FB12FA1Q28067133-10441EDB-5763-42EC-84C8-4D8A1D448367Q28076486-C185BE98-F469-415A-8681-BAE41D0D65DAQ28082445-A2C4612A-2071-4239-B1C5-D2DC0F47B062Q28083109-E6DDDF9D-0DD2-4016-9AF0-5F6517A8D1B7Q28084519-EE85C885-2714-403D-A6CE-E761A3666529Q28289458-7CBF097C-ADF8-4889-BDC3-6FD078CD806CQ28290437-1F0C1A22-C709-4E16-A3F1-03256125AC21Q28307770-38152A64-B256-4F80-BD75-5AA6D20C40DBQ28597251-B31794D5-201A-4667-87BE-9C98FF0B9C10Q28741033-471180C2-2878-4E36-A028-3FC268D80486Q28751133-69AEBB31-7918-4FCD-9646-A0E59E52A3B3Q28943449-819726A5-F43E-48DB-AA0C-FA34AEE0BCA0Q30369745-1052F172-5303-4485-AFBB-5FFBEE36BC86Q30384240-18B6E0CA-545E-4775-847F-FEE4815C3510Q30387636-758F2C13-4824-4AEB-A2DE-4E691B7F6E8DQ30391706-4F5F82CF-2015-49F1-B52D-365E47FF98C2Q30433955-C2CC942B-D60A-41BA-9251-DA1510DC6A00
P2860
Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@ast
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@en
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@en-gb
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@nl
type
label
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@ast
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@en
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@en-gb
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@nl
prefLabel
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@ast
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@en
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@en-gb
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@nl
P2093
P2860
P50
P3181
P1433
P1476
Lifetime and 12-month prevalen ...... Comorbidity Survey replication
@en
P2093
Kathleen R Merikangas
Maria Petukhova
Paul E Greenberg
Robert M A Hirschfeld
P2860
P304
P3181
P356
10.1001/ARCHPSYC.64.5.543
P407
P577
2007-05-01T00:00:00Z